LIMNW
Liminatus Pharma, Inc. Warrants
NASDAQ · Healthcare · Biotechnology · US
$0.06
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.96x
- Price / sales
- —
- Price / cash flow
- -0.38x
Enterprise value
- Enterprise value
- -$83.8K
- EV / sales
- —
- EV / EBITDA
- 0.01x
- EV / EBIT
- 0.02x
- Market cap
- $1.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026